Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Infections 2Soft Tissue Infections 1Neutropenia 1Lymphoma, Follicular 1Fournier Gangrene 1Fasciitis, Necrotizing 1

Interventions

fludarabine phosphate 15Cyclophosphamide 15Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 10Filgrastim 10Mycophenolic Acid 9Busulfan 8Antilymphocyte Serum 7Radiotherapy 5Methylprednisolone 5Melphalan 5Therapeutics 4Psychiatric Rehabilitation 4Methotrexate 4Exercise 4Etoposide 4Cord Blood Stem Cell Transplantation 4Blood Specimen Collection 4fludarabine 3Rituximab 3Prednisone 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3Aprepitant 3Analgesia 3plerixafor 2Tacrolimus 2Standard of Care 2Ondansetron 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Follicular × Daptomycin × Clear all
NCT00261807 2022-01-27

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

University of Maryland, Baltimore

Phase NA Completed
25 enrolled 7 charts
Lymphoid

Infections, Lymphoma, Follicular, Soft Tissue Infections, Fournier Gangrene, Fasciitis, Necrotizing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡